Insider transactions Beam Therapeutics Inc.

Stocks

BEAM

US07373V1052

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 10/07/2026 BST			5-day change	1st Jan Change
32.68 ^USD	-8.77%		-6.06%	+17.89%

07-08	Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration; Shares Rise	MT
07-08	Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration	MT

Insider Transaction History

Latest insider transactions for Beam Therapeutics Inc.

Date	Insider	Type	Main position	Quantity	Price	Amount	% Market Cap.
06-29	John Evans	Fiscal year	Chief Executive Officer	75,000	17.67	883K	0.0729%
06-29	Amy Simon	Sell	Chief Technology Officer	-373	34.73	-	0.0004%
06-25	F-Prime Inc.	Sell	Company	-251,488	35.26	-	0.2444%
06-16	Giuseppe Ciaramella	Fiscal year	Chairperson	71,010	0.96	34.23K	0.0690%
06-02	Chirfi Guindo	Free	Director	19,676	29.78	586K	0.0191%
06-02	Kathleen Walsh	Free	Director	19,676	29.78	586K	0.0191%
06-02	Christi Shaw	Free	Director	19,676	29.78	586K	0.0191%
06-02	Graham Cooper	Free	Director	19,676	29.78	586K	0.0191%
06-02	John Maraganore	Free	Director	19,676	29.78	586K	0.0191%
06-02	Mark Fishman	Free	Director	19,676	29.78	586K	0.0191%
03-31	John Evans	Sell	Chief Executive Officer	30,078	24.58	739K	0.0295%
03-31	Giuseppe Ciaramella	Sell	Chairperson	11,810	24.58	290K	0.0116%
03-31	Bethany Cavanagh	Sell	Controller/Auditor	3,242	24.58	79.69K	0.0032%
03-31	Amy Simon	Sell	Chief Technology Officer	6,700	24.58	165K	0.0066%
03-31	Christine Bellon	Sell	General Counsel	5,956	24.58	146K	0.0058%
03-30	Amy Simon	Free	Chief Technology Officer	31,750	-	-	0.0312%
03-30	Sravan Emany	Free	Chief Financial Officer	31,750	-	-	0.0312%
03-30	Bethany Cavanagh	Free	Controller/Auditor	20,000	-	-	0.0196%
03-30	Giuseppe Ciaramella	Free	Chairperson	40,000	-	-	0.0393%
03-30	Christine Bellon	Free	General Counsel	20,000	-	-	0.0196%
03-29	John Evans	Fiscal year	Chief Executive Officer	240,000	6.11	1.16M	0.2356%
02-23	Giuseppe Ciaramella	Fiscal year	Chairperson	105,000	24.50	1.72M	0.1035%
01-30	Christine Bellon	Free	General Counsel	40,000	-	-	0.0394%
01-30	Amy Simon	Free	Chief Technology Officer	88,500	-	-	0.0872%
01-30	Sravan Emany	Free	Chief Financial Officer	63,500	-	-	0.0626%
01-30	Giuseppe Ciaramella	Free	Chairperson	80,000	-	-	0.0788%
01-30	Bethany Cavanagh	Free	Controller/Auditor	40,000	-	-	0.0394%
01-28	John Evans	Fiscal year	Chief Executive Officer	330,000	14.77	1.48M	0.3252%
01-21	Christine Bellon	Sell	General Counsel	1,371	34.00	46.61K	0.0014%
01-21	Bethany Cavanagh	Sell	Controller/Auditor	6,198	35.00	217K	0.0061%
01-19	Bethany Cavanagh	Sell	Controller/Auditor	3,034	30.12	91.38K	0.0030%
01-14	Christine Bellon	Sell	General Counsel	18,629	34.62	645K	0.0184%
12-30	Christine Bellon	Sell	General Counsel	1,254	27.10	33.98K	0.0012%
12-30	Amy Simon	Free	Chief Technology Officer	12,500	-	-	0.0123%
12-30	Sravan Emany	Sell	Chief Financial Officer	6,294	27.10	171K	0.0062%
26/10/25	F-Prime, Inc.	Other	Company	459	26.68	12.25K	0.0005%
05/10/25	F-Prime, Inc.	Other	Company	0	-	-	0%
05/10/25	FMR LLC	Other	Company	0	-	-	0%
05/10/25	Fidelity Management & Research Co. LLC	Don	Company	1,232,434	-	-	1.2183%
30/09/25	Bethany Cavanagh	Sell	Controller/Auditor	467	24.53	11.46K	0.0005%
30/09/25	John Evans	Fiscal year	Chief Executive Officer	150,000	12.62	1.26M	0.1483%
30/09/25	Christine Bellon	Sell	General Counsel	373	24.53	9.15K	0.0004%
29/07/25	F-Prime, Inc.	Other	Company	48,374	20.50	992K	0.0481%
30/06/25	Amy Simon	Sell	Chief Technology Officer	1,250	19.17	23.96K	0.0012%
03/06/25	Graham Cooper	Free	Director	33,662	-	-	0.0335%
03/06/25	Christi Shaw	Free	Director	33,662	-	-	0.0335%
03/06/25	Chirfi Guindo	Free	Director	33,662	-	-	0.0335%
03/06/25	Mark Fishman	Free	Director	33,662	-	-	0.0335%
03/06/25	Carole Ho	Free	Director	33,662	-	-	0.0335%
03/06/25	John Maraganore	Free	Director	33,662	-	-	0.0335%